Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5476 AL 5490

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

Gauthier S, Leuzy A, Racine E, Rosa-Neto P.

Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8.

[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]

Cruz Jentoft AJ, Hernández B.

Neurologia. 2014 Jan-Feb;29(1):1-10. doi: 10.1016/j.nrl.2013.01.008. Epub 2013 Apr 10.

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings

Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, Argimon JM, Bruno G, Novick D, Vellas B, Haro JM.

J Alzheimers Dis. 2013;36(2):385-99. doi: 10.3233/JAD-122392.

Video prompting versus other instruction strategies for persons with Alzheimer's disease

Perilli V, Lancioni GE, Hoogeveen F, Caffó A, Singh N, O'Reilly M, Sigafoos J, Cassano G, Oliva D.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):393-402. doi: 10.1177/1533317513488913. Epub 2013 May 17.

The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: study protocol for a randomized controlled trial

Chiatti C, Masera F, Rimland JM, Cherubini A, Scarpino O, Spazzafumo L, Lattanzio F; UP-TECH research group.

Trials. 2013 May 28;14:155. doi: 10.1186/1745-6215-14-155.

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

Freiherr J, Hallschmid M, Frey WH 2nd, Brünner YF, Chapman CD, Hölscher C, Craft S, De Felice FG, Benedict C.

CNS Drugs. 2013 Jul;27(7):505-14. doi: 10.1007/s40263-013-0076-8.

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors

Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.

CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.

Intravenous immunoglobulin and Alzheimer's disease: what now?

Loeffler DA.

J Neuroinflammation. 2013 Jun 5;10:70. doi: 10.1186/1742-2094-10-70.

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.

BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.

Need for and challenges facing functional communication as outcome parameter in AD clinical trials

Haberstroh J, Wollstadt P, Knebel M, Oswald F, Schröder J, Pantel J.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):293-301. doi: 10.1097/WAD.0b013e318299d28d.

Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease

Asano M, Ishitobi M, Tanaka Y, Wada Y.

J Clin Psychopharmacol. 2013 Aug;33(4):579-81. doi: 10.1097/JCP.0b013e3182946702.

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease

Rive B, Gauthier S, Costello S, Marre C, François C.

CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x.

The benzazole scaffold: a SWAT to combat Alzheimer's disease

Noël S, Cadet S, Gras E, Hureau C.

Chem Soc Rev. 2013 Oct 7;42(19):7747-62. doi: 10.1039/c3cs60086f. Epub 2013 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias